Article Text
PostScript
Correspondence
Safety of long-acting β-agonists in asthma
Statistics from Altmetric.com
- Asthma
- asthma guidelines
- asthma pharmacology
- asthma epidemiology
- asthma in primary care
- bronchiectasis
- empyema
- paediatric asthma
- paediatric lung disease
The study by Wolfe et al 1 certainly does not support our claim that serious asthma exacerbations are more frequent in patients receiving formoterol 24 μg twice daily than in those receiving …
Footnotes
Competing interests None.
Provenance and peer review Not commissioned; internally peer reviewed.